Breaking News Instant updates and real-time market news.

UNH

UnitedHealth

$220.32

-1.69 (-0.76%)

06:02
10/15/19
10/15
06:02
10/15/19
06:02

UnitedHealth raises FY19 adj. EPS $14.90-$15.00, consensus $14.83

Based on strong Q3 results and its positive view for the rest of the year, UnitedHealth increased its full year net earnings outlook to $14.15 to $14.25 per share and adjusted net earnings to a range of $14.90 to $15.00 per share, both increasing 15c per share at the mid-point.

  • 15

    Oct

UNH UnitedHealth
$220.32

-1.69 (-0.76%)

10/08/19
CANT
10/08/19
NO CHANGE
Target $310
CANT
Overweight
UnitedHealth pullback on policy noise an opportunity, says Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper says shares of UnitedHealth are attractive at current levels. He reiterates an Overweight rating on the name with a $310 price target ahead of the company's Q3 results on October 15. Optum will continue to be a strong growth driver for UnitedHealth, driven by solid performance across all three of the unit's operating segments, Halper tells investors in a pre-earnings research note. The analyst continue believe sweeping changes to the U.S. healthcare system, which has pressured the stock, are unlikely. Policy noise has created an attractive buying opportunity into UnitedHealth, says Halper.
10/10/19
JEFF
10/10/19
DOWNGRADE
Target $235
JEFF
Hold
UnitedHealth downgraded to Hold from Buy at Jefferies
Jefferies analyst David Windley downgraded UnitedHealth to Hold from Buy with a price target of $235, down from $300.
10/10/19
JEFF
10/10/19
DOWNGRADE
Target $235
JEFF
Hold
Jefferies downgrades UnitedHealth to Hold, cuts Managed Care price targets
Jefferies analyst David Windley downgraded UnitedHealth (UNH) to Hold from Buy with a price target of $235, down from $300. Managed Care sentiment "turned abruptly negative a year ago and has stubbornly remained there," Windley tells investors in a research note. Further, the political risk causing this won't likely abate for at least another nine months, contends the analyst. In addition to the political overhang, he's concerned UnitedHealth's (UNH) commercial enrollment is at risk to Anthem (ANTM). Along with the downgrade of UnitedHealth, Windley cut his price target for Buy-rated Anthem to $299 from $365, for Buy-rated Centene (CNC) to $53 from $76, for Buy-rated Cigna (CI) to $203 from $233, for Buy-rated Humana (HUM) to $322 from $352, for Buy-rated Molina Healthcare (MOH) to $133 from $173 and for Hold-rated WellCare (WCG) to $264 from $302.
10/10/19
RHCO
10/10/19
NO CHANGE
Target $330
RHCO
Hold
SunTrust 'bullish' across healthcare services space ahead of Q3 results
SunTrust analyst David MacDonald says he remains "bullish" across much of the healthcare services space ahead of third quarter results, citing "solid" core trends, "attractive" secular tailwinds, "robust" M&A and "strong" free cash flow. While he expects ongoing intermittent "chop" as industry noise continues to weigh, he views the risk of meaningful structural change as quite low, continues to favor scaled, integrated providers in the ongoing shift towards value and views valuation risk/rewards as increasingly attractive. The analyst tells investors in a research note that he does not necessarily view Q3 results as a meaningful trigger and thinks improved visibility around the election and Democratic primary is key, MacDonald remains bullish on core fundamentals, sees significant inherent sector drivers and says Managed Care remains a favorite fundamental sector. The analyst raised his price target for Anthem (ANTM) to $330 from $290, on Centene (CNC) to $80 from $72, on Cigna (CI) to $260 from $230, on Humana (HUM) to $340 from $310, on Molina (MOH) to $180 from $165, on UnitedHealth (UNH) to $330 from $310, on WellCare (WCG) to $340 from $320, on Ensign Group (ENSG) to $60 from $44 and Tivity Health (TVTY) to $24 from $21.

TODAY'S FREE FLY STORIES

HOG

Harley-Davidson

$36.86

-0.705 (-1.88%)

07:45
11/20/19
11/20
07:45
11/20/19
07:45
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

GFF

Griffon

$21.98

-0.45 (-2.01%)

07:43
11/20/19
11/20
07:43
11/20/19
07:43
Conference/Events
Griffon management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

GDDY

GoDaddy

$68.24

-0.05 (-0.07%)

07:42
11/20/19
11/20
07:42
11/20/19
07:42
Conference/Events
GoDaddy management to meet with Wedbush »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

  • 09

    Dec

TJX

TJX

$60.66

1.12 (1.88%)

07:42
11/20/19
11/20
07:42
11/20/19
07:42
Recommendations
TJX analyst commentary  »

TJX price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AMRN

Amarin

$22.74

0.11 (0.49%)

, MDCO

The Medicines Co.

$70.17

11.51 (19.62%)

07:41
11/20/19
11/20
07:41
11/20/19
07:41
Recommendations
Citi prefers Amarin shares to The Medicines Co. after this week's divergence »

Amarin (AMRN) shares this…

AMRN

Amarin

$22.74

0.11 (0.49%)

MDCO

The Medicines Co.

$70.17

11.51 (19.62%)

NVS

Novartis

$90.42

0.14 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 28

    Dec

FTDR

Frontdoor

$45.68

1.26 (2.84%)

07:41
11/20/19
11/20
07:41
11/20/19
07:41
Conference/Events
Frontdoor management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

RCI

Rogers Communications

$47.86

(0.00%)

, AMZN

Amazon.com

$1,752.17

-0.53 (-0.03%)

07:40
11/20/19
11/20
07:40
11/20/19
07:40
Hot Stocks
Rogers announces availability of Amazon Prime Video on Ignite TV »

Rogers (RCI) announced…

RCI

Rogers Communications

$47.86

(0.00%)

AMZN

Amazon.com

$1,752.17

-0.53 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

RJF

Raymond James

$89.25

-0.06 (-0.07%)

07:40
11/20/19
11/20
07:40
11/20/19
07:40
Initiation
Raymond James initiated  »

Raymond James initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:40
11/20/19
11/20
07:40
11/20/19
07:40
General news
Treasury Market Outlook: yields continued to fall overnight »

Treasury Market Outlook:…

KSS

Kohl's

$47.01

-11.38 (-19.49%)

07:39
11/20/19
11/20
07:39
11/20/19
07:39
Recommendations
Kohl's analyst commentary  »

Kohl's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

FRPT

Freshpet

$54.37

-0.1 (-0.18%)

07:39
11/20/19
11/20
07:39
11/20/19
07:39
Conference/Events
Freshpet management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HLI

Houlihan Lokey

$47.69

0.18 (0.38%)

07:38
11/20/19
11/20
07:38
11/20/19
07:38
Initiation
Houlihan Lokey initiated  »

Houlihan Lokey initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$16.43

0.335 (2.08%)

07:38
11/20/19
11/20
07:38
11/20/19
07:38
Conference/Events
Flexion management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HOLX

Hologic

$47.17

0.43 (0.92%)

07:37
11/20/19
11/20
07:37
11/20/19
07:37
Hot Stocks
Hologic to sell its Cynosure business for $205M, to enter new $205M ASR »

Hologic announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTOO

T2 Biosystems

$1.82

0.07 (4.00%)

07:37
11/20/19
11/20
07:37
11/20/19
07:37
Hot Stocks
T2 Biosystems announces granting of CE Mark for T2Resistance Panel »

T2 Biosystems and CARB-X…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$359.52

9.53 (2.72%)

07:37
11/20/19
11/20
07:37
11/20/19
07:37
Recommendations
Tesla analyst commentary  »

Tesla's base…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAZ

Lazard

$37.61

0.12 (0.32%)

07:36
11/20/19
11/20
07:36
11/20/19
07:36
Initiation
Lazard initiated  »

Lazard initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AHC

A.H. Belo

$3.15

0.03 (0.96%)

07:35
11/20/19
11/20
07:35
11/20/19
07:35
Hot Stocks
A.H. Belo announces restatement, receives NYSE notice on late 10-Q filing »

A. H. Belo Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBA

Pembina Pipeline

$36.21

0.04 (0.11%)

07:34
11/20/19
11/20
07:34
11/20/19
07:34
Hot Stocks
Pembina Pipeline's acquisition of Kinder Morgan Canada approved by CCB »

Pembina Pipeline and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVR

Evercore Partners

$76.43

0.64 (0.84%)

07:34
11/20/19
11/20
07:34
11/20/19
07:34
Initiation
Evercore Partners initiated  »

Evercore Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VVUS

VIVUS

$2.84

0.09 (3.27%)

07:33
11/20/19
11/20
07:33
11/20/19
07:33
Hot Stocks
VIVUS announces results of clinical study of Qysmia in patients with BED, BN »

VIVUS announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WWD

Woodward

$115.83

2.19 (1.93%)

07:32
11/20/19
11/20
07:32
11/20/19
07:32
Downgrade
Woodward rating change  »

Woodward downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

HOLX

Hologic

$47.17

0.43 (0.92%)

07:32
11/20/19
11/20
07:32
11/20/19
07:32
Hot Stocks
Clayton, Dubilier & Rice to acquire Cynosure from Hologic »

Clayton, Dubilier &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.07

-0.05 (-0.11%)

07:31
11/20/19
11/20
07:31
11/20/19
07:31
Recommendations
Endava analyst commentary  »

Endava price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

MYOS

MYOS

$1.49

(0.00%)

07:31
11/20/19
11/20
07:31
11/20/19
07:31
Hot Stocks
MYOS' Fortetropin shows muscle increase in accepted clinical trial presentation »

MYOS RENS, owner of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.